Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: With the limited time before expiration ( Cautious

I was emailed the following today, made in February 2006, and it highlights the anticipation felt then. Sadly, with the passage of time, knowledge of the actual fee structure, and interventions at the USPTO, the euphoria had to be tempered by these, and other, factors.

Those figures from halcyon days are but a reminder of what might have determined an investment in PTSC, and subsequent rise in price to over $2. The price declined as more details were known, and continued doing so with every new piece of information until recently when, on current information, the price started to rise again.

No matter who is on the BoD, the intervening events make those figures purely academic for that time, and anyone who believes a newly constituted BoD can bring those back will be denying every external factor which has given rise to the current price, and the recent external positives which will help the price rise.

Shareholder value has to be based on what there is now, and not on some memory of the past.

In the event that all 150 infringers settle @ $10m each to Patriot, wouldn't that equate to $5 per share? If there then follows a 1% net royalty payment of the total market, would that be $7 per share(2% - $14; 3% - $21; 4% - $28; 5% - $35)?

As each case is settled, will it become more expensive for those infringers that are delaying payment?

With 10 years left on the patents, unless extended, and assuming 1% royalty, might there be $75($400 @ 5%)per share available for dividend payments?

What price Patriot when the settlements start rolling in then?

.

.

.

Be well

Share
New Message
Please login to post a reply